Glucagon-like peptide-1(GLP-1), a peptide hormone secreted by intestinal L-cells, has broad pharmacological potential for managing type 2 diabetes mellitus and metabolic syndrome-related disorders by binding to its receptor -GLP-1R. This evidence concerns the gene GLP1R and diabetes mellitus.